Extended Data Fig. 1: Association of clinical response with survival. | Nature Medicine

Extended Data Fig. 1: Association of clinical response with survival.

From: Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial

Extended Data Fig. 1

a. Probability of progression-free survival in patients with partial and complete response (n = 11) and patients with stable disease and progression (n = 23). b. Probability of overall survival in patients with partial and complete response (n = 11) and patients with stable disease and progression (n = 23). Significance was evaluated by the Log-rank (Mantel-Cox) test.

Back to article page